Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.44
-1.98 (-0.85%)
AAPL  284.95
-1.24 (-0.43%)
AMD  217.04
+1.80 (0.84%)
BAC  54.12
+0.93 (1.75%)
GOOG  321.49
+5.47 (1.73%)
META  644.82
-2.28 (-0.35%)
MSFT  482.98
-7.02 (-1.43%)
NVDA  180.62
-0.84 (-0.46%)
ORCL  207.52
+6.42 (3.19%)
TSLA  445.63
+16.39 (3.82%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.